

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of leukocyte degranulation (GO:0043302) | 9.90648786 |
| 2 | regulation of podosome assembly (GO:0071801) | 9.52689921 |
| 3 | positive regulation of granulocyte differentiation (GO:0030854) | 9.13753791 |
| 4 | tyrosine phosphorylation of STAT protein (GO:0007260) | 8.60367023 |
| 5 | positive regulation of chemokine secretion (GO:0090197) | 8.59852554 |
| 6 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 8.32874467 |
| 7 | behavioral response to nicotine (GO:0035095) | 8.30927421 |
| 8 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 7.94423421 |
| 9 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 7.85799341 |
| 10 | signal peptide processing (GO:0006465) | 7.60171813 |
| 11 | regulation of mast cell degranulation (GO:0043304) | 7.34767285 |
| 12 | positive regulation of regulated secretory pathway (GO:1903307) | 7.17153788 |
| 13 | regulation of proton transport (GO:0010155) | 7.09305169 |
| 14 | leukotriene biosynthetic process (GO:0019370) | 7.02976681 |
| 15 | regulation of chemokine secretion (GO:0090196) | 6.94040084 |
| 16 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 6.92549121 |
| 17 | regulation of mast cell activation involved in immune response (GO:0033006) | 6.92297643 |
| 18 | positive regulation of megakaryocyte differentiation (GO:0045654) | 6.87676728 |
| 19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.68330076 |
| 20 | peptide hormone processing (GO:0016486) | 6.42552188 |
| 21 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 6.27956562 |
| 22 | positive regulation of immunoglobulin production (GO:0002639) | 6.27893372 |
| 23 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 6.04175621 |
| 24 | regulation of immunoglobulin secretion (GO:0051023) | 6.00441451 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 5.67088267 |
| 26 | regulation of transforming growth factor beta production (GO:0071634) | 5.65065973 |
| 27 | regulation of granulocyte differentiation (GO:0030852) | 5.56884453 |
| 28 | regulation of leukocyte degranulation (GO:0043300) | 5.47011019 |
| 29 | regulation of transforming growth factor beta1 production (GO:0032908) | 5.39560930 |
| 30 | regulation of macrophage activation (GO:0043030) | 5.22572571 |
| 31 | regulation of mast cell activation (GO:0033003) | 5.20118352 |
| 32 | inositol phosphate-mediated signaling (GO:0048016) | 5.02140884 |
| 33 | positive regulation of B cell proliferation (GO:0030890) | 4.84981001 |
| 34 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.75719237 |
| 35 | regulation of regulated secretory pathway (GO:1903305) | 4.64172912 |
| 36 | positive regulation of acute inflammatory response (GO:0002675) | 4.62997639 |
| 37 | negative regulation of meiosis (GO:0045835) | 4.58482382 |
| 38 | regulation of immunoglobulin production (GO:0002637) | 4.42995134 |
| 39 | negative regulation of appetite (GO:0032099) | 4.39210853 |
| 40 | negative regulation of response to food (GO:0032096) | 4.39210853 |
| 41 | leukotriene metabolic process (GO:0006691) | 4.35031573 |
| 42 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.31676723 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.18928449 |
| 44 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 4.18109853 |
| 45 | positive regulation of macrophage differentiation (GO:0045651) | 4.14898917 |
| 46 | monoamine transport (GO:0015844) | 4.14004903 |
| 47 | cytokine biosynthetic process (GO:0042089) | 3.96475298 |
| 48 | viral protein processing (GO:0019082) | 3.94806210 |
| 49 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.87773981 |
| 50 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.86946765 |
| 51 | cytokine metabolic process (GO:0042107) | 3.86436028 |
| 52 | positive regulation of organelle assembly (GO:1902117) | 3.86067962 |
| 53 | positive regulation of JAK-STAT cascade (GO:0046427) | 3.76802303 |
| 54 | membrane repolarization during action potential (GO:0086011) | 3.74304193 |
| 55 | mast cell degranulation (GO:0043303) | 3.73971159 |
| 56 | mast cell activation involved in immune response (GO:0002279) | 3.73971159 |
| 57 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.70588918 |
| 58 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.70588918 |
| 59 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 3.66915894 |
| 60 | protein carboxylation (GO:0018214) | 3.66071767 |
| 61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66071767 |
| 62 | cell proliferation in forebrain (GO:0021846) | 3.64848248 |
| 63 | regulation of B cell proliferation (GO:0030888) | 3.61457547 |
| 64 | tolerance induction (GO:0002507) | 3.58011449 |
| 65 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50192380 |
| 66 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.46014228 |
| 67 | thrombin receptor signaling pathway (GO:0070493) | 3.43209538 |
| 68 | protein complex biogenesis (GO:0070271) | 3.42451617 |
| 69 | positive regulation of B cell mediated immunity (GO:0002714) | 3.41881369 |
| 70 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.41881369 |
| 71 | positive regulation of fatty acid oxidation (GO:0046321) | 3.41600510 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.36456624 |
| 73 | actin nucleation (GO:0045010) | 3.34404686 |
| 74 | positive regulation of B cell activation (GO:0050871) | 3.32712577 |
| 75 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.31420429 |
| 76 | cytokine production involved in immune response (GO:0002367) | 3.28189197 |
| 77 | lung lobe morphogenesis (GO:0060463) | 3.25744398 |
| 78 | mast cell activation (GO:0045576) | 3.25237213 |
| 79 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.24758689 |
| 80 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.24234181 |
| 81 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.23850777 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.21933058 |
| 83 | transmission of nerve impulse (GO:0019226) | 3.21777177 |
| 84 | protein polyglutamylation (GO:0018095) | 3.21073106 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.18824130 |
| 86 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.17786361 |
| 87 | parturition (GO:0007567) | 3.11725203 |
| 88 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.10570401 |
| 89 | negative regulation of blood pressure (GO:0045776) | 3.10367280 |
| 90 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.09850584 |
| 91 | retinal ganglion cell axon guidance (GO:0031290) | 3.08666298 |
| 92 | regulation of response to food (GO:0032095) | 3.07063235 |
| 93 | regulation of appetite (GO:0032098) | 3.05994406 |
| 94 | magnesium ion transport (GO:0015693) | 3.05318842 |
| 95 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.04442681 |
| 96 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.04305290 |
| 97 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.03989836 |
| 98 | nonmotile primary cilium assembly (GO:0035058) | 3.03489295 |
| 99 | kidney morphogenesis (GO:0060993) | 3.03399154 |
| 100 | NADH dehydrogenase complex assembly (GO:0010257) | 3.02227579 |
| 101 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.02227579 |
| 102 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.02227579 |
| 103 | G-protein coupled receptor internalization (GO:0002031) | 2.99680695 |
| 104 | positive regulation of myeloid cell differentiation (GO:0045639) | 2.97359288 |
| 105 | regulation of JAK-STAT cascade (GO:0046425) | 2.94246870 |
| 106 | regulation of macrophage differentiation (GO:0045649) | 2.94073868 |
| 107 | epithelial cilium movement (GO:0003351) | 2.93859278 |
| 108 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.93293357 |
| 109 | detection of light stimulus involved in visual perception (GO:0050908) | 2.93293357 |
| 110 | somite development (GO:0061053) | 2.91570813 |
| 111 | positive regulation of exocytosis (GO:0045921) | 2.91435835 |
| 112 | muscle organ morphogenesis (GO:0048644) | 2.90160586 |
| 113 | negative regulation of meiotic cell cycle (GO:0051447) | 2.89436863 |
| 114 | sulfation (GO:0051923) | 2.88616365 |
| 115 | fucose catabolic process (GO:0019317) | 2.88206663 |
| 116 | L-fucose metabolic process (GO:0042354) | 2.88206663 |
| 117 | L-fucose catabolic process (GO:0042355) | 2.88206663 |
| 118 | regulation of megakaryocyte differentiation (GO:0045652) | 2.87126038 |
| 119 | icosanoid biosynthetic process (GO:0046456) | 2.85884712 |
| 120 | fatty acid derivative biosynthetic process (GO:1901570) | 2.85884712 |
| 121 | axoneme assembly (GO:0035082) | 2.84160202 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.83964255 |
| 123 | nucleobase catabolic process (GO:0046113) | 2.83867221 |
| 124 | regulation of mesoderm development (GO:2000380) | 2.83645190 |
| 125 | negative regulation of membrane potential (GO:0045837) | 2.83584395 |
| 126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83454703 |
| 127 | synaptic transmission, cholinergic (GO:0007271) | 2.82355412 |
| 128 | membrane repolarization (GO:0086009) | 2.81418400 |
| 129 | tryptophan catabolic process (GO:0006569) | 2.81380234 |
| 130 | indole-containing compound catabolic process (GO:0042436) | 2.81380234 |
| 131 | indolalkylamine catabolic process (GO:0046218) | 2.81380234 |
| 132 | tooth mineralization (GO:0034505) | 2.81373433 |
| 133 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 2.79986025 |
| 134 | regulation of action potential (GO:0098900) | 2.79695523 |
| 135 | * indolalkylamine metabolic process (GO:0006586) | 2.79661627 |
| 136 | dentate gyrus development (GO:0021542) | 2.78435647 |
| 137 | virion assembly (GO:0019068) | 2.78403611 |
| 138 | kynurenine metabolic process (GO:0070189) | 2.77271066 |
| 139 | dendritic spine morphogenesis (GO:0060997) | 2.76074466 |
| 140 | limb development (GO:0060173) | 2.75489500 |
| 141 | appendage development (GO:0048736) | 2.75489500 |
| 142 | positive regulation of astrocyte differentiation (GO:0048711) | 2.74211216 |
| 143 | T cell migration (GO:0072678) | 2.72028943 |
| 144 | regulation of membrane repolarization (GO:0060306) | 2.70241500 |
| 145 | activation of phospholipase C activity (GO:0007202) | 2.68362305 |
| 146 | negative regulation of neurological system process (GO:0031645) | 2.68329048 |
| 147 | cornea development in camera-type eye (GO:0061303) | 2.66018853 |
| 148 | spinal cord motor neuron differentiation (GO:0021522) | 2.64752965 |
| 149 | otic vesicle formation (GO:0030916) | 2.64113841 |
| 150 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.64067488 |
| 151 | lung vasculature development (GO:0060426) | 2.63588466 |
| 152 | cellular anion homeostasis (GO:0030002) | 2.63525602 |
| 153 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.61617573 |
| 154 | reflex (GO:0060004) | 2.60723881 |
| 155 | regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 2.60690107 |
| 156 | lipoxygenase pathway (GO:0019372) | 2.60597530 |
| 157 | positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 2.60276435 |
| 158 | cilium movement (GO:0003341) | 2.59836275 |
| 159 | neuronal action potential (GO:0019228) | 2.58620830 |
| 160 | regulation of interleukin-5 production (GO:0032674) | 2.55243151 |
| 161 | regulation of B cell mediated immunity (GO:0002712) | 2.55241725 |
| 162 | glycerophospholipid catabolic process (GO:0046475) | 2.54780688 |
| 163 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.54730615 |
| 164 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.54730615 |
| 165 | lung secretory cell differentiation (GO:0061140) | 2.54498591 |
| 166 | regulation of cilium movement (GO:0003352) | 2.54052653 |
| 167 | multicellular organismal signaling (GO:0035637) | 2.53093869 |
| 168 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.52996570 |
| 169 | negative regulation of bone resorption (GO:0045779) | 2.52304706 |
| 170 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.52299665 |
| 171 | regulation of T-helper 1 type immune response (GO:0002825) | 2.51840751 |
| 172 | presynaptic membrane organization (GO:0097090) | 2.50217157 |
| 173 | regulation of sequestering of triglyceride (GO:0010889) | 2.49809144 |
| 174 | cytochrome complex assembly (GO:0017004) | 2.49777542 |
| 175 | DNA deamination (GO:0045006) | 2.49064206 |
| 176 | regulation of DNA endoreduplication (GO:0032875) | 2.46645497 |
| 177 | positive regulation of fatty acid transport (GO:2000193) | 2.45409234 |
| 178 | pharyngeal system development (GO:0060037) | 2.44713451 |
| 179 | regulation of neurotransmitter uptake (GO:0051580) | 2.44042903 |
| 180 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.43529277 |
| 181 | cellular response to ATP (GO:0071318) | 2.42837070 |
| 182 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.42446691 |
| 183 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.42446691 |
| 184 | nephron tubule morphogenesis (GO:0072078) | 2.41851031 |
| 185 | nephron epithelium morphogenesis (GO:0072088) | 2.41851031 |
| 186 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.41442334 |
| 187 | calcium ion import (GO:0070509) | 2.40846179 |
| 188 | presynaptic membrane assembly (GO:0097105) | 2.39712335 |
| 189 | cell differentiation in spinal cord (GO:0021515) | 2.37686798 |
| 190 | piRNA metabolic process (GO:0034587) | 2.37181507 |
| 191 | neuron fate determination (GO:0048664) | 2.36357249 |
| 192 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.33467140 |
| 193 | negative regulation of response to nutrient levels (GO:0032108) | 2.33467140 |
| 194 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 13.1462040 |
| 195 | positive regulation of mast cell degranulation (GO:0043306) | 13.1462040 |
| 196 | angiotensin maturation (GO:0002003) | 12.9894955 |
| 197 | positive regulation of macrophage activation (GO:0043032) | 12.5869185 |
| 198 | regulation of hypersensitivity (GO:0002883) | 12.1546740 |
| 199 | positive regulation of mast cell activation (GO:0033005) | 10.8401481 |
| 200 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 10.7478439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.57430978 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.05441855 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.76349305 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.59483006 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.99985075 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97116754 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.92284755 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90465474 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88892122 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.79086931 |
| 11 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.72647208 |
| 12 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.70658070 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53923264 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.53223243 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52119182 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.51046057 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47580518 |
| 18 | GATA1_19941826_ChIP-Seq_K562_Human | 2.47492675 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.46781441 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46659388 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39275084 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.37986973 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.35644098 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.31603840 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28853296 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.18697723 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18653422 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17755697 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.08652112 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.08072790 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08072737 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.07675679 |
| 33 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.03519623 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01638631 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.01442702 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.01063219 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00974821 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.0979804 |
| 39 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.95094801 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.93439348 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.93358141 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89196889 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.88781424 |
| 44 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.85599789 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84094015 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82901180 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82642373 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82401937 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81762973 |
| 50 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.77044862 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72509021 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72473281 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71082718 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70844026 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65435670 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65399446 |
| 57 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62663985 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61999309 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60687383 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60534910 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60364876 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59953431 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58577049 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58274210 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56748385 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.55635810 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53409007 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49200918 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49003397 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48979462 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48845695 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48750105 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48296955 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46496208 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46248601 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.46121316 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.46121316 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.46121293 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46054239 |
| 80 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44450696 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43389478 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43322672 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41951902 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41096488 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39435783 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.37463141 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36087817 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35172412 |
| 89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34868139 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34118337 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32582790 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32508226 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32441887 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32441887 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32245930 |
| 96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31263668 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30502400 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30055952 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.29994110 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29979355 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29814050 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28712012 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27655422 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27410402 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27410402 |
| 106 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27133684 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26629555 |
| 108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26019200 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25328329 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25140461 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24793946 |
| 112 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24286509 |
| 113 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24122901 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23844687 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23748390 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23570552 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22577660 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22409907 |
| 119 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22223876 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20335210 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20191774 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18862949 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17623952 |
| 124 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.17572055 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17510785 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17136659 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16703758 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16316106 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15821798 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15404287 |
| 131 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15317797 |
| 132 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15151046 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13538250 |
| 134 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13075849 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13055430 |
| 136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12784194 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09959753 |
| 138 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08802574 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06438659 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06406269 |
| 141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05973885 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05569629 |
| 143 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03366155 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03161798 |
| 145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02177518 |
| 146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01753941 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01753941 |
| 148 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01159990 |
| 149 | MAF_26560356_Chip-Seq_TH2_Human | 1.01095640 |
| 150 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00735466 |
| 151 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00349086 |
| 152 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00121213 |
| 153 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99981367 |
| 154 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.99852326 |
| 155 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99542825 |
| 156 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99542825 |
| 157 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98865346 |
| 158 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98710010 |
| 159 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98261357 |
| 160 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98027773 |
| 161 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97067330 |
| 162 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96759339 |
| 163 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.96750672 |
| 164 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.96569451 |
| 165 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96288918 |
| 166 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96044454 |
| 167 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95893457 |
| 168 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95673754 |
| 169 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95079747 |
| 170 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94260329 |
| 171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93853718 |
| 172 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91568265 |
| 173 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90946643 |
| 174 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90840148 |
| 175 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90309369 |
| 176 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90298375 |
| 177 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87688028 |
| 178 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86254340 |
| 179 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85191309 |
| 180 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.83565946 |
| 181 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83009207 |
| 182 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82621235 |
| 183 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81903372 |
| 184 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81687299 |
| 185 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81425209 |
| 186 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81109936 |
| 187 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80223400 |
| 188 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.78278280 |
| 189 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76618305 |
| 190 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76344837 |
| 191 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76254273 |
| 192 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75884677 |
| 193 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74839337 |
| 194 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74021920 |
| 195 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.73392381 |
| 196 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.71841325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003045_fibrosis | 6.69620081 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 4.28264424 |
| 3 | MP0003646_muscle_fatigue | 4.06435659 |
| 4 | MP0005671_abnormal_response_to | 3.64965719 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.60945109 |
| 6 | MP0003638_abnormal_response/metabolism_ | 3.48145928 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.37794875 |
| 8 | MP0005387_immune_system_phenotype | 3.35870369 |
| 9 | MP0001790_abnormal_immune_system | 3.35870369 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 3.34255449 |
| 11 | MP0004510_myositis | 2.93557352 |
| 12 | MP0001800_abnormal_humoral_immune | 2.83381048 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.75621596 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.67747218 |
| 15 | MP0005025_abnormal_response_to | 2.66564638 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.63289400 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.56354242 |
| 18 | MP0003866_abnormal_defecation | 2.55660686 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.53847999 |
| 20 | MP0003436_decreased_susceptibility_to | 2.50989509 |
| 21 | MP0005166_decreased_susceptibility_to | 2.44094274 |
| 22 | MP0003724_increased_susceptibility_to | 2.42999009 |
| 23 | MP0001819_abnormal_immune_cell | 2.32344990 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.32154449 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.30409496 |
| 26 | MP0002168_other_aberrant_phenotype | 2.26569655 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 2.25875322 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.25485285 |
| 29 | MP0002723_abnormal_immune_serum | 2.13499918 |
| 30 | MP0002398_abnormal_bone_marrow | 2.10223622 |
| 31 | MP0002735_abnormal_chemical_nociception | 2.10066308 |
| 32 | MP0002160_abnormal_reproductive_system | 2.02647158 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.97759204 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.95285990 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.94727498 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.93057094 |
| 37 | MP0003303_peritoneal_inflammation | 1.93032625 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.92639533 |
| 39 | MP0009745_abnormal_behavioral_response | 1.86958194 |
| 40 | MP0005310_abnormal_salivary_gland | 1.86455664 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.86062982 |
| 42 | MP0003011_delayed_dark_adaptation | 1.84725743 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.82269913 |
| 44 | MP0002272_abnormal_nervous_system | 1.81363471 |
| 45 | MP0002419_abnormal_innate_immunity | 1.80876061 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.78339757 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 1.77689869 |
| 48 | MP0004130_abnormal_muscle_cell | 1.77548482 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.76813769 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.76614899 |
| 51 | MP0004133_heterotaxia | 1.70463839 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.66466918 |
| 53 | MP0003195_calcinosis | 1.65950284 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.65889857 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.64973091 |
| 56 | MP0004947_skin_inflammation | 1.63585150 |
| 57 | MP0000716_abnormal_immune_system | 1.63399155 |
| 58 | MP0009046_muscle_twitch | 1.61812213 |
| 59 | MP0003787_abnormal_imprinting | 1.58004392 |
| 60 | MP0000477_abnormal_intestine_morphology | 1.57943166 |
| 61 | MP0003122_maternal_imprinting | 1.56858192 |
| 62 | MP0003879_abnormal_hair_cell | 1.55707360 |
| 63 | MP0005389_reproductive_system_phenotype | 1.54915785 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.53129866 |
| 65 | MP0002163_abnormal_gland_morphology | 1.51725227 |
| 66 | MP0002429_abnormal_blood_cell | 1.50346568 |
| 67 | MP0003880_abnormal_central_pattern | 1.50305015 |
| 68 | MP0004142_abnormal_muscle_tone | 1.50300162 |
| 69 | MP0002722_abnormal_immune_system | 1.48547969 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.47929715 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.44009568 |
| 72 | MP0004742_abnormal_vestibular_system | 1.43526665 |
| 73 | MP0006082_CNS_inflammation | 1.43194729 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.42845750 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.42511794 |
| 76 | MP0000026_abnormal_inner_ear | 1.41891923 |
| 77 | MP0000230_abnormal_systemic_arterial | 1.39299756 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.37091897 |
| 79 | MP0002938_white_spotting | 1.37026349 |
| 80 | MP0002184_abnormal_innervation | 1.35760056 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 1.35643294 |
| 82 | MP0002736_abnormal_nociception_after | 1.34764895 |
| 83 | MP0000049_abnormal_middle_ear | 1.33957327 |
| 84 | MP0001486_abnormal_startle_reflex | 1.30545012 |
| 85 | MP0002064_seizures | 1.30319346 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.29414166 |
| 87 | MP0002102_abnormal_ear_morphology | 1.28183260 |
| 88 | MP0001727_abnormal_embryo_implantation | 1.27819384 |
| 89 | MP0001440_abnormal_grooming_behavior | 1.27814284 |
| 90 | MP0008872_abnormal_physiological_respon | 1.26139702 |
| 91 | MP0008469_abnormal_protein_level | 1.26050695 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.25923490 |
| 93 | MP0003121_genomic_imprinting | 1.25844138 |
| 94 | MP0001188_hyperpigmentation | 1.25463118 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 1.25396906 |
| 96 | MP0001873_stomach_inflammation | 1.24566833 |
| 97 | MP0002396_abnormal_hematopoietic_system | 1.23192398 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 1.22522228 |
| 99 | MP0001542_abnormal_bone_strength | 1.21574886 |
| 100 | * MP0002572_abnormal_emotion/affect_behav | 1.21520011 |
| 101 | MP0004215_abnormal_myocardial_fiber | 1.21486053 |
| 102 | MP0010307_abnormal_tumor_latency | 1.21160652 |
| 103 | MP0000703_abnormal_thymus_morphology | 1.19383771 |
| 104 | MP0002405_respiratory_system_inflammati | 1.19097683 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 1.17700671 |
| 106 | MP0005253_abnormal_eye_physiology | 1.17082639 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 1.16984924 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 1.15571740 |
| 109 | * MP0001970_abnormal_pain_threshold | 1.15276547 |
| 110 | MP0001963_abnormal_hearing_physiology | 1.13813036 |
| 111 | MP0001501_abnormal_sleep_pattern | 1.13488273 |
| 112 | MP0002752_abnormal_somatic_nervous | 1.11439897 |
| 113 | MP0000778_abnormal_nervous_system | 1.10905462 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 1.10438881 |
| 115 | MP0001905_abnormal_dopamine_level | 1.09357141 |
| 116 | MP0000249_abnormal_blood_vessel | 1.08045106 |
| 117 | MP0001986_abnormal_taste_sensitivity | 1.07253323 |
| 118 | MP0002822_catalepsy | 1.05861507 |
| 119 | MP0002063_abnormal_learning/memory/cond | 1.05596590 |
| 120 | MP0001502_abnormal_circadian_rhythm | 1.05371187 |
| 121 | MP0009785_altered_susceptibility_to | 1.04472336 |
| 122 | MP0002928_abnormal_bile_duct | 1.04299994 |
| 123 | MP0005195_abnormal_posterior_eye | 1.04129322 |
| 124 | MP0004147_increased_porphyrin_level | 1.03973676 |
| 125 | MP0002998_abnormal_bone_remodeling | 1.03832788 |
| 126 | MP0000685_abnormal_immune_system | 1.03810921 |
| 127 | MP0005448_abnormal_energy_balance | 1.02577383 |
| 128 | MP0003123_paternal_imprinting | 1.02484990 |
| 129 | MP0010329_abnormal_lipoprotein_level | 1.02349902 |
| 130 | MP0003119_abnormal_digestive_system | 1.00534201 |
| 131 | MP0000372_irregular_coat_pigmentation | 1.00106329 |
| 132 | MP0001984_abnormal_olfaction | 0.99467495 |
| 133 | MP0003938_abnormal_ear_development | 0.99207476 |
| 134 | MP0008873_increased_physiological_sensi | 0.99207098 |
| 135 | MP0001851_eye_inflammation | 0.99160493 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.99013630 |
| 137 | MP0002067_abnormal_sensory_capabilities | 0.97931463 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.97824630 |
| 139 | * MP0004085_abnormal_heartbeat | 0.96040510 |
| 140 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95384471 |
| 141 | MP0005395_other_phenotype | 0.95012591 |
| 142 | MP0001881_abnormal_mammary_gland | 0.94823487 |
| 143 | * MP0002733_abnormal_thermal_nociception | 0.93729612 |
| 144 | MP0004043_abnormal_pH_regulation | 0.92996075 |
| 145 | MP0008770_decreased_survivor_rate | 0.92944858 |
| 146 | MP0001919_abnormal_reproductive_system | 0.92826110 |
| 147 | MP0002277_abnormal_respiratory_mucosa | 0.90127683 |
| 148 | MP0000427_abnormal_hair_cycle | 0.89574081 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.89320376 |
| 150 | MP0005499_abnormal_olfactory_system | 0.89320376 |
| 151 | MP0002229_neurodegeneration | 0.88763573 |
| 152 | * MP0008775_abnormal_heart_ventricle | 0.88632398 |
| 153 | MP0005332_abnormal_amino_acid | 0.88197611 |
| 154 | MP0009763_increased_sensitivity_to | 0.86216718 |
| 155 | MP0009780_abnormal_chondrocyte_physiolo | 0.85896791 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.85611232 |
| 157 | MP0000516_abnormal_urinary_system | 0.84908423 |
| 158 | MP0005367_renal/urinary_system_phenotyp | 0.84908423 |
| 159 | MP0002882_abnormal_neuron_morphology | 0.83592236 |
| 160 | MP0000490_abnormal_crypts_of | 0.83408300 |
| 161 | MP0003942_abnormal_urinary_system | 0.83392175 |
| 162 | MP0001853_heart_inflammation | 0.82335258 |
| 163 | MP0003283_abnormal_digestive_organ | 0.81873951 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.78677253 |
| 165 | MP0000689_abnormal_spleen_morphology | 0.74782976 |
| 166 | MP0003795_abnormal_bone_structure | 0.74192179 |
| 167 | MP0005390_skeleton_phenotype | 0.70721225 |
| 168 | MP0005646_abnormal_pituitary_gland | 0.70220290 |
| 169 | MP0005174_abnormal_tail_pigmentation | 0.70067300 |
| 170 | MP0005248_abnormal_Harderian_gland | 0.68862169 |
| 171 | MP0002933_joint_inflammation | 0.68119664 |
| 172 | MP0004885_abnormal_endolymph | 0.65746761 |
| 173 | MP0001663_abnormal_digestive_system | 0.62039788 |
| 174 | MP0002254_reproductive_system_inflammat | 0.60730823 |
| 175 | MP0003172_abnormal_lysosome_physiology | 0.56355188 |
| 176 | MP0002086_abnormal_extraembryonic_tissu | 0.54812840 |
| 177 | MP0000639_abnormal_adrenal_gland | 0.52863265 |
| 178 | MP0005645_abnormal_hypothalamus_physiol | 0.52741936 |
| 179 | MP0003763_abnormal_thymus_physiology | 0.52451107 |
| 180 | MP0004185_abnormal_adipocyte_glucose | 0.51191676 |
| 181 | MP0006054_spinal_hemorrhage | 0.49216937 |
| 182 | MP0000858_altered_metastatic_potential | 0.48979824 |
| 183 | MP0005075_abnormal_melanosome_morpholog | 0.46629752 |
| 184 | MP0002557_abnormal_social/conspecific_i | 0.45151516 |
| 185 | MP0004858_abnormal_nervous_system | 0.43020219 |
| 186 | MP0001849_ear_inflammation | 0.41763819 |
| 187 | MP0003448_altered_tumor_morphology | 0.41583594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Purpura (HP:0000979) | 8.02587404 |
| 2 | Abnormal platelet volume (HP:0011876) | 7.96404928 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.91135425 |
| 4 | Menorrhagia (HP:0000132) | 7.75030165 |
| 5 | Gingival bleeding (HP:0000225) | 7.59174112 |
| 6 | Prolonged bleeding time (HP:0003010) | 7.44696087 |
| 7 | Abnormal platelet function (HP:0011869) | 6.86930799 |
| 8 | Impaired platelet aggregation (HP:0003540) | 6.86930799 |
| 9 | IgM deficiency (HP:0002850) | 5.20702427 |
| 10 | Epistaxis (HP:0000421) | 4.17406131 |
| 11 | Papilledema (HP:0001085) | 4.13881519 |
| 12 | Pancreatic cysts (HP:0001737) | 3.89387241 |
| 13 | Chronic otitis media (HP:0000389) | 3.69758377 |
| 14 | Sex reversal (HP:0012245) | 3.63062358 |
| 15 | Abnormal sex determination (HP:0012244) | 3.63062358 |
| 16 | Pancreatic fibrosis (HP:0100732) | 3.56682284 |
| 17 | Decreased circulating renin level (HP:0003351) | 3.45226759 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.41883185 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.41883185 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 3.40144556 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.32532087 |
| 22 | True hermaphroditism (HP:0010459) | 3.32369907 |
| 23 | Nephronophthisis (HP:0000090) | 3.31087015 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.18959756 |
| 25 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.11072232 |
| 26 | B lymphocytopenia (HP:0010976) | 3.08394425 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.08394425 |
| 28 | Abnormality of binocular vision (HP:0011514) | 3.07154037 |
| 29 | Diplopia (HP:0000651) | 3.07154037 |
| 30 | Type II lissencephaly (HP:0007260) | 3.04345894 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.93946051 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.92692946 |
| 33 | Short tibia (HP:0005736) | 2.90269388 |
| 34 | Recurrent fungal infections (HP:0002841) | 2.85894344 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.83619774 |
| 36 | Aplastic anemia (HP:0001915) | 2.81129744 |
| 37 | Bruising susceptibility (HP:0000978) | 2.75361630 |
| 38 | Recurrent viral infections (HP:0004429) | 2.68586300 |
| 39 | Genetic anticipation (HP:0003743) | 2.66723801 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.63124525 |
| 41 | Pendular nystagmus (HP:0012043) | 2.61577063 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.59623627 |
| 43 | Cellulitis (HP:0100658) | 2.58720531 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.58353093 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.57565866 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.55724852 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.51592318 |
| 48 | Cystic liver disease (HP:0006706) | 2.51378098 |
| 49 | Short 4th metacarpal (HP:0010044) | 2.50949758 |
| 50 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.50949758 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.50904723 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.47717131 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.46767278 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.46258810 |
| 55 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.45520400 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45259266 |
| 57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.45193028 |
| 58 | Methylmalonic aciduria (HP:0012120) | 2.42567929 |
| 59 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41994105 |
| 60 | Mesomelia (HP:0003027) | 2.41449705 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.40346731 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.38584251 |
| 63 | Increased IgE level (HP:0003212) | 2.38177305 |
| 64 | IgA deficiency (HP:0002720) | 2.36718989 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.36369348 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.35203134 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33680568 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.33680568 |
| 69 | Hypercortisolism (HP:0001578) | 2.33664777 |
| 70 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.31629729 |
| 71 | Hyperventilation (HP:0002883) | 2.28185622 |
| 72 | Tubular atrophy (HP:0000092) | 2.27786142 |
| 73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.23713131 |
| 74 | Decreased central vision (HP:0007663) | 2.23501631 |
| 75 | Abnormality of the 4th metacarpal (HP:0010012) | 2.23161426 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22436829 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22436829 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22436829 |
| 79 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.21100235 |
| 80 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20669699 |
| 81 | Chronic hepatic failure (HP:0100626) | 2.18928620 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.17445078 |
| 83 | Polydipsia (HP:0001959) | 2.17445078 |
| 84 | Cervical subluxation (HP:0003308) | 2.16919308 |
| 85 | Hyperglycinemia (HP:0002154) | 2.15867262 |
| 86 | Short femoral neck (HP:0100864) | 2.15389012 |
| 87 | Asplenia (HP:0001746) | 2.15034491 |
| 88 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.14944038 |
| 89 | Hyperacusis (HP:0010780) | 2.14046727 |
| 90 | Increased corneal curvature (HP:0100692) | 2.13447532 |
| 91 | Keratoconus (HP:0000563) | 2.13447532 |
| 92 | Hypoplasia of the uterus (HP:0000013) | 2.12293204 |
| 93 | Heterochromia iridis (HP:0001100) | 2.11831816 |
| 94 | Fibular hypoplasia (HP:0003038) | 2.11237643 |
| 95 | Hypoplasia of the ulna (HP:0003022) | 2.10902655 |
| 96 | Clumsiness (HP:0002312) | 2.10788802 |
| 97 | White forelock (HP:0002211) | 2.10680587 |
| 98 | Anencephaly (HP:0002323) | 2.09678347 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.08769129 |
| 100 | Sclerocornea (HP:0000647) | 2.08271297 |
| 101 | Abnormal ciliary motility (HP:0012262) | 2.07160883 |
| 102 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.06534627 |
| 103 | Acute myeloid leukemia (HP:0004808) | 2.06315530 |
| 104 | Insomnia (HP:0100785) | 2.05830205 |
| 105 | Gait imbalance (HP:0002141) | 2.04594513 |
| 106 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.03610012 |
| 107 | Abnormality of T cells (HP:0002843) | 2.03045626 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02956716 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02956716 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02956716 |
| 111 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.01810870 |
| 112 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.01810870 |
| 113 | Eczematoid dermatitis (HP:0000976) | 2.00984741 |
| 114 | Male pseudohermaphroditism (HP:0000037) | 2.00587233 |
| 115 | Abnormality of the renal collecting system (HP:0004742) | 2.00335939 |
| 116 | Petechiae (HP:0000967) | 11.1763361 |
| 117 | Apathy (HP:0000741) | 1.99836807 |
| 118 | Patellar aplasia (HP:0006443) | 1.98766787 |
| 119 | Megalencephaly (HP:0001355) | 1.98413464 |
| 120 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.97893060 |
| 121 | Adrenal overactivity (HP:0002717) | 1.97336448 |
| 122 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.96294565 |
| 123 | Vertebral hypoplasia (HP:0008417) | 1.96294565 |
| 124 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.95845722 |
| 125 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95468894 |
| 126 | Nasal polyposis (HP:0100582) | 1.95158086 |
| 127 | Facial shape deformation (HP:0011334) | 1.94592364 |
| 128 | Potter facies (HP:0002009) | 1.94592364 |
| 129 | Gaze-evoked nystagmus (HP:0000640) | 1.93985421 |
| 130 | Severe short stature (HP:0003510) | 1.93101246 |
| 131 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.93067409 |
| 132 | Congenital primary aphakia (HP:0007707) | 1.93065125 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.91982516 |
| 134 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91570810 |
| 135 | Stenosis of the external auditory canal (HP:0000402) | 1.90980795 |
| 136 | Fibular aplasia (HP:0002990) | 1.88960237 |
| 137 | Slender build (HP:0001533) | 1.88529302 |
| 138 | Progressive hearing impairment (HP:0001730) | 1.87129008 |
| 139 | Genital tract atresia (HP:0001827) | 1.86884957 |
| 140 | Attenuation of retinal blood vessels (HP:0007843) | 1.86713554 |
| 141 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.85848966 |
| 142 | Absent/shortened dynein arms (HP:0200106) | 1.85848966 |
| 143 | Cerebellar dysplasia (HP:0007033) | 1.85506279 |
| 144 | Vaginal atresia (HP:0000148) | 1.84791720 |
| 145 | Abnormality of alanine metabolism (HP:0010916) | 1.84754352 |
| 146 | Hyperalaninemia (HP:0003348) | 1.84754352 |
| 147 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84754352 |
| 148 | Germ cell neoplasia (HP:0100728) | 1.84078263 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.83322367 |
| 150 | Retinal dysplasia (HP:0007973) | 1.83270642 |
| 151 | Morphological abnormality of the middle ear (HP:0008609) | 1.82971481 |
| 152 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.82630473 |
| 153 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.82400300 |
| 154 | Urticaria (HP:0001025) | 1.82081951 |
| 155 | Neoplasm of the rectum (HP:0100743) | 1.81934538 |
| 156 | Abnormality of renal excretion (HP:0011036) | 1.81732161 |
| 157 | Pachygyria (HP:0001302) | 1.80651451 |
| 158 | Furrowed tongue (HP:0000221) | 1.80479341 |
| 159 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.80377562 |
| 160 | Adrenal hypoplasia (HP:0000835) | 1.80279356 |
| 161 | Concave nail (HP:0001598) | 1.79171349 |
| 162 | Short hallux (HP:0010109) | 1.78731178 |
| 163 | Diminished motivation (HP:0000745) | 1.78518886 |
| 164 | Confusion (HP:0001289) | 1.77991028 |
| 165 | Colitis (HP:0002583) | 1.77900071 |
| 166 | Neoplasm of head and neck (HP:0012288) | 1.77675474 |
| 167 | Esophageal neoplasm (HP:0100751) | 1.77675474 |
| 168 | Congenital hepatic fibrosis (HP:0002612) | 1.75975030 |
| 169 | Thyroid-stimulating hormone excess (HP:0002925) | 1.75725697 |
| 170 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75626886 |
| 171 | Abnormality of the gastric mucosa (HP:0004295) | 1.75378792 |
| 172 | Patchy hypopigmentation of hair (HP:0011365) | 1.74976876 |
| 173 | Poikilocytosis (HP:0004447) | 1.74890406 |
| 174 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74306199 |
| 175 | Agitation (HP:0000713) | 1.69922049 |
| 176 | Recurrent sinusitis (HP:0011108) | 1.68071309 |
| 177 | Increased density of long bones (HP:0006392) | 1.64975873 |
| 178 | Abnormality of oral frenula (HP:0000190) | 1.62692194 |
| 179 | Vasculitis (HP:0002633) | 1.62649875 |
| 180 | Neoplasm of the small intestine (HP:0100833) | 1.61426435 |
| 181 | Supranuclear gaze palsy (HP:0000605) | 1.61066321 |
| 182 | Hyperaldosteronism (HP:0000859) | 1.61008120 |
| 183 | Leukocytosis (HP:0001974) | 1.58770297 |
| 184 | Posterior subcapsular cataract (HP:0007787) | 1.56316759 |
| 185 | Disproportionate tall stature (HP:0001519) | 1.53339558 |
| 186 | Chest pain (HP:0100749) | 1.53296843 |
| 187 | Cerebral aneurysm (HP:0004944) | 1.53116107 |
| 188 | Bronchitis (HP:0012387) | 1.52939266 |
| 189 | T lymphocytopenia (HP:0005403) | 1.51636978 |
| 190 | Recurrent skin infections (HP:0001581) | 1.50771610 |
| 191 | Hyperparathyroidism (HP:0000843) | 1.46646851 |
| 192 | Chronic obstructive pulmonary disease (HP:0006510) | 1.45826703 |
| 193 | Obstructive lung disease (HP:0006536) | 1.45826703 |
| 194 | Lymphopenia (HP:0001888) | 1.42870732 |
| 195 | Abnormality of eosinophils (HP:0001879) | 1.42426856 |
| 196 | Abnormality of the fingertips (HP:0001211) | 1.42413305 |
| 197 | Progressive neurologic deterioration (HP:0002344) | 1.41867792 |
| 198 | Abnormality of the nasal mucosa (HP:0000433) | 1.40958035 |
| 199 | Restrictive lung disease (HP:0002091) | 1.40759215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.10353848 |
| 2 | TAOK3 | 5.60559975 |
| 3 | KIT | 4.56825282 |
| 4 | MAP4K1 | 4.05390795 |
| 5 | FES | 3.33167194 |
| 6 | TLK1 | 3.15226175 |
| 7 | ADRBK2 | 3.11640985 |
| 8 | MATK | 2.84724408 |
| 9 | PINK1 | 2.70285114 |
| 10 | EEF2K | 2.68213160 |
| 11 | GRK1 | 2.64120611 |
| 12 | GRK6 | 2.51212414 |
| 13 | WNK4 | 2.43247822 |
| 14 | TXK | 2.38347816 |
| 15 | MAP4K2 | 2.33207989 |
| 16 | CDK6 | 2.31371918 |
| 17 | WNK3 | 2.31224764 |
| 18 | TRIB3 | 2.25474760 |
| 19 | PKN2 | 2.24805412 |
| 20 | ZAK | 2.24293865 |
| 21 | JAK1 | 2.16268750 |
| 22 | CASK | 2.16226342 |
| 23 | ZAP70 | 2.13068598 |
| 24 | BLK | 2.12771493 |
| 25 | BMPR1B | 2.02031659 |
| 26 | ACVR1B | 2.00545608 |
| 27 | ALK | 1.97166078 |
| 28 | FGFR2 | 1.92327095 |
| 29 | MAP3K4 | 1.89527952 |
| 30 | SYK | 1.89031361 |
| 31 | INSRR | 1.77581728 |
| 32 | RIPK4 | 1.68257573 |
| 33 | NUAK1 | 1.65311889 |
| 34 | SIK2 | 1.64219918 |
| 35 | DYRK2 | 1.61531222 |
| 36 | PIK3CA | 1.60030631 |
| 37 | HIPK2 | 1.57104644 |
| 38 | MAPK13 | 1.52064990 |
| 39 | TYK2 | 1.48299145 |
| 40 | JAK2 | 1.48112211 |
| 41 | JAK3 | 1.43754737 |
| 42 | STK39 | 1.42137207 |
| 43 | NTRK2 | 1.41177579 |
| 44 | NTRK3 | 1.38366264 |
| 45 | DMPK | 1.35122612 |
| 46 | SIK1 | 1.33398321 |
| 47 | NME1 | 1.30698195 |
| 48 | MARK1 | 1.27464096 |
| 49 | MAP2K7 | 1.24921734 |
| 50 | SGK223 | 1.22824043 |
| 51 | SGK494 | 1.22824043 |
| 52 | PTK6 | 1.21344055 |
| 53 | ADRBK1 | 1.15811859 |
| 54 | TEC | 1.15473407 |
| 55 | LYN | 1.15171079 |
| 56 | BMX | 1.13433934 |
| 57 | PAK3 | 1.12572628 |
| 58 | OXSR1 | 1.12300172 |
| 59 | PRKCG | 1.11053741 |
| 60 | PASK | 1.09442256 |
| 61 | TNK2 | 1.08203238 |
| 62 | TGFBR2 | 1.08093272 |
| 63 | EPHB2 | 1.07878923 |
| 64 | MAPK15 | 1.05778738 |
| 65 | BTK | 1.04745366 |
| 66 | ITK | 1.04699154 |
| 67 | TIE1 | 1.04005424 |
| 68 | FGFR4 | 1.02768639 |
| 69 | PTK2 | 1.02732115 |
| 70 | SGK2 | 1.02661253 |
| 71 | PRKCE | 1.01690561 |
| 72 | STK11 | 1.01457553 |
| 73 | PHKG1 | 1.01415013 |
| 74 | PHKG2 | 1.01415013 |
| 75 | MAPKAPK2 | 1.00411039 |
| 76 | BCKDK | 1.00265595 |
| 77 | LRRK2 | 0.99764599 |
| 78 | MAPKAPK3 | 0.99688657 |
| 79 | HCK | 0.99396365 |
| 80 | MAPKAPK5 | 0.98507571 |
| 81 | PIK3CG | 0.97094593 |
| 82 | EPHA4 | 0.95170532 |
| 83 | STK16 | 0.93049516 |
| 84 | EPHB1 | 0.91831502 |
| 85 | UHMK1 | 0.91703803 |
| 86 | SCYL2 | 0.91369131 |
| 87 | RPS6KB2 | 0.91029251 |
| 88 | NME2 | 0.90718754 |
| 89 | CDK4 | 0.85282269 |
| 90 | MAP3K9 | 0.84444147 |
| 91 | PIM2 | 0.84379518 |
| 92 | STK10 | 0.84320549 |
| 93 | MAP2K6 | 0.82673711 |
| 94 | LCK | 0.81533946 |
| 95 | TNIK | 0.81263629 |
| 96 | PRKD2 | 0.81135413 |
| 97 | RPS6KA6 | 0.78052755 |
| 98 | ERBB2 | 0.76713035 |
| 99 | NEK2 | 0.76610384 |
| 100 | STK38L | 0.75497704 |
| 101 | CAMK1G | 0.74061197 |
| 102 | PLK2 | 0.73275277 |
| 103 | PIM1 | 0.72452333 |
| 104 | NEK9 | 0.71633193 |
| 105 | PRKCQ | 0.68828326 |
| 106 | TBK1 | 0.68544441 |
| 107 | MKNK2 | 0.67640220 |
| 108 | SGK1 | 0.67019326 |
| 109 | CSNK1A1 | 0.66322643 |
| 110 | PRKCZ | 0.66121309 |
| 111 | RPS6KA2 | 0.65676176 |
| 112 | * PRKACA | 0.65001948 |
| 113 | CSNK1G2 | 0.62567330 |
| 114 | PDK1 | 0.62214089 |
| 115 | MINK1 | 0.60598527 |
| 116 | CAMK2A | 0.58965315 |
| 117 | DYRK3 | 0.58042466 |
| 118 | MAP2K4 | 0.57490685 |
| 119 | MAP2K2 | 0.56828317 |
| 120 | MAP3K14 | 0.55372168 |
| 121 | IKBKB | 0.55031410 |
| 122 | PRKACB | 0.54668428 |
| 123 | CAMK1 | 0.54066584 |
| 124 | PRKCB | 0.53365109 |
| 125 | PRKCA | 0.52996614 |
| 126 | RPS6KA5 | 0.51782650 |
| 127 | SRC | 0.51353564 |
| 128 | CSNK1G1 | 0.50784105 |
| 129 | MUSK | 0.50263218 |
| 130 | CDK9 | 0.50252352 |
| 131 | PRKCI | 0.50074242 |
| 132 | VRK1 | 0.49691774 |
| 133 | CAMKK1 | 0.49455029 |
| 134 | FGFR3 | 0.48128554 |
| 135 | * PRKACG | 0.47925962 |
| 136 | TAOK1 | 0.45726268 |
| 137 | BRSK2 | 0.45589107 |
| 138 | CLK1 | 0.45304988 |
| 139 | DYRK1A | 0.45291357 |
| 140 | ILK | 0.44747155 |
| 141 | CSNK1G3 | 0.44405806 |
| 142 | TGFBR1 | 0.43203599 |
| 143 | PDPK1 | 0.42403779 |
| 144 | PKN1 | 0.40976280 |
| 145 | GRK7 | 0.40546259 |
| 146 | CSF1R | 0.40497772 |
| 147 | NLK | 0.39563552 |
| 148 | EPHA3 | 0.39306196 |
| 149 | PAK2 | 0.39186526 |
| 150 | PRKG1 | 0.39143808 |
| 151 | PRKG2 | 0.38665325 |
| 152 | RET | 0.37727694 |
| 153 | GRK5 | 0.36454723 |
| 154 | MAPK11 | 0.36149969 |
| 155 | FYN | 0.35601712 |
| 156 | FGR | 0.35042387 |
| 157 | TYRO3 | 0.34018847 |
| 158 | OBSCN | 0.33625369 |
| 159 | CAMK2D | 0.32936778 |
| 160 | GSK3A | 0.32724522 |
| 161 | MAPK4 | 0.32614453 |
| 162 | PRKCH | 0.32611649 |
| 163 | PNCK | 0.32383993 |
| 164 | ABL2 | 0.31685970 |
| 165 | DAPK2 | 0.31425707 |
| 166 | STK3 | 0.30832637 |
| 167 | FGFR1 | 0.30801812 |
| 168 | PRKAA1 | 0.30257783 |
| 169 | SGK3 | 0.29885632 |
| 170 | MAP2K1 | 0.27552079 |
| 171 | PDGFRB | 0.26957845 |
| 172 | IRAK3 | 0.25059223 |
| 173 | MAP3K2 | 0.25056818 |
| 174 | CAMK1D | 0.24992611 |
| 175 | TRPM7 | 0.24990688 |
| 176 | MAP3K7 | 0.24719129 |
| 177 | CAMKK2 | 0.24127882 |
| 178 | LIMK1 | 0.23892680 |
| 179 | RPS6KL1 | 0.23300483 |
| 180 | RPS6KC1 | 0.23300483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.99335835 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.65600059 |
| 3 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 3.45748151 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.80094682 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.67402357 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61495174 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58330108 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54670075 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37325081 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.22776661 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08593018 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.04141846 |
| 13 | Asthma_Homo sapiens_hsa05310 | 13.0516822 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.94686901 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93986776 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.88335501 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.85610810 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.76718691 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71347197 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66153472 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62475258 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62340112 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.58277114 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57515978 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49188529 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47946370 |
| 27 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46706262 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45436419 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.43458956 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42887072 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41146014 |
| 32 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.39930039 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39893418 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.39136362 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38237961 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36802064 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35917985 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34521885 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29346626 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28944963 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.28551900 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25580907 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20665742 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.17040224 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14544338 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12184616 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08395545 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05808694 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02263701 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00530709 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.00370037 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.92552609 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91275946 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88191141 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87236393 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.86130559 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85876066 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85146429 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83365055 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83016888 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82575646 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.80669225 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76376240 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75364651 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.74728844 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74110810 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.74107364 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72932695 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.67816265 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67742614 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67590294 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64438679 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.62042161 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61947660 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61721565 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60610345 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.60216365 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58715133 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57163982 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56342143 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.56053205 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55993758 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55278661 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54256262 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.53815515 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53614064 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52285044 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52172594 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51902582 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51103610 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49101811 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46856904 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46834856 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46022185 |
| 95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45477575 |
| 96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44910431 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44713899 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43950156 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42896470 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42752083 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42569531 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40050172 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39267959 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39229416 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39019250 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.38966463 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.38651459 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37892742 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.35568942 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35259830 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34508375 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34106118 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33873474 |
| 114 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.32858172 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32792975 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31859953 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31563437 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30889889 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30763801 |
| 120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27860297 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27100371 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26542871 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25420670 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.25313535 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24954468 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24882839 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24672311 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24556664 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24530474 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.23767099 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23236323 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22075480 |
| 133 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21882130 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21587734 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21364383 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.19170010 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17798417 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.17335349 |
| 139 | Long-term potentiation_Homo sapiens_hsa04720 | 0.17150831 |
| 140 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16488118 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.16424502 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15550659 |
| 143 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15266655 |
| 144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13148451 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13031531 |
| 146 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.12838489 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12129190 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.11899540 |
| 149 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.11751103 |
| 150 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.11683691 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11599854 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.11201463 |
| 153 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10830329 |
| 154 | Shigellosis_Homo sapiens_hsa05131 | 0.10289446 |
| 155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09834769 |
| 156 | Insulin resistance_Homo sapiens_hsa04931 | 0.09646011 |
| 157 | Amoebiasis_Homo sapiens_hsa05146 | 0.08692224 |
| 158 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08249825 |
| 159 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08149862 |
| 160 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.08087236 |
| 161 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07906290 |
| 162 | Focal adhesion_Homo sapiens_hsa04510 | 0.07873910 |
| 163 | Morphine addiction_Homo sapiens_hsa05032 | 0.07263507 |
| 164 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.06766354 |
| 165 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.06246565 |
| 166 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.05795720 |
| 167 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.05562828 |
| 168 | Histidine metabolism_Homo sapiens_hsa00340 | 0.05459938 |
| 169 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.05362039 |
| 170 | Bladder cancer_Homo sapiens_hsa05219 | 0.04976884 |
| 171 | Endocytosis_Homo sapiens_hsa04144 | 0.04784565 |
| 172 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04707826 |
| 173 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.04690245 |
| 174 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04625509 |
| 175 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.04546485 |

